CFO’s $0.59 Share Purchase Signals IceCure’s Confidence in a Comeback Amid 23% Insider Stake and Strategic Pivot
IceCure CFO’s 23 % insider buy signals confidence amid a shaky stock, offering a potential price lift as the company pushes its cryoablation platform into U.S. markets.
4 minutes to read